Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
对于新诊断的急性髓系白血病，在可测量的残留病灶指导下，使用高剂量维奈托克治疗后停用阿扎胞苷。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.282681
Gutman, Jonathan A; Winters, Amanda; Kent, Andrew; Amaya, Maria; McMahon, Christine; Smith, Clayton; Jordan, Craig T; Stevens, Brett; Minhajuddin, Mohammad; Pei, Shanshan; Schowinsky, Jeffrey; Tobin, Jennifer; O'Brien, Kelly; Falco, Angela; Taylor, Elizabeth; Brecl, Constance; Zhou, Katie; Ho, Phuong; Sohalski, Connor; Dell-Martin, Jessica; Ondracek, Olivia; Abbott, Diana; Pollyea, Daniel A
